Vanberra Signal
ZuCoinChain logo

ZuCoinChain

Curated by Signal

Diversified blockchain services platform enabling smart investments for all.

Overview

ZuCoinChain operates as a blockchain financial services provider, offering a cryptocurrency ecosystem that includes an investment platform, crypto wallet, gaming platform, and streaming service. The company targets customers interested in cryptocurrencies and aims to facilitate investments for individuals across various income levels through the use of artificial intelligence and transparent statistics. The platform seeks to address the need for accessible financial services by providing a suite of tools and utilities within a single interface. ZuCoinChain is regulated in the UK and has established strategic partnerships, focusing on adapting to the evolving demands of the cryptocurrency market.

Key facts

Founded
2019
Headquarters
United States

Business model

More on Vanberra Signal

Members only

Competitors & similar companies

More Decentralized Finance companies
  • Comprehensive blockchain financial services platform for digital currency trading.

    Decentralized FinanceSydney, Australia
  • Blockchain platform delivering finance, HR, and legal services securely.

    Decentralized FinanceSingapore, Singapore
  • Blockchain financial services bridging cryptocurrency and conventional markets.

    Decentralized FinanceBrno, Czech Republic
+ 401 more similar companies on Signal

About ZuCoinChain

What does ZuCoinChain do?

ZuCoinChain operates as a blockchain financial services provider, offering a cryptocurrency ecosystem that includes an investment platform, crypto wallet, gaming platform, and streaming service.

Where is ZuCoinChain headquartered?

ZuCoinChain is headquartered in United States.

When was ZuCoinChain founded?

ZuCoinChain was founded in 2019.

Which sector is ZuCoinChain in?

ZuCoinChain operates in Decentralized Finance, part of Financial Technology.

Who are ZuCoinChain's competitors?

Companies similar to ZuCoinChain include Clanz, Cosmeta, and Probinex.